[HTML][HTML] Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity
C Fougeroux, L Goksøyr, M Idorn, V Soroka… - Nature …, 2021 - nature.com
The rapid development of a SARS-CoV-2 vaccine is a global priority. Here, we develop two
capsid-like particle (CLP)-based vaccines displaying the receptor-binding domain (RBD) of …
capsid-like particle (CLP)-based vaccines displaying the receptor-binding domain (RBD) of …
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity
C Fougeroux, L Goksøyr, M Idorn… - Nature …, 2021 - pubmed.ncbi.nlm.nih.gov
The rapid development of a SARS-CoV-2 vaccine is a global priority. Here, we develop two
capsid-like particle (CLP)-based vaccines displaying the receptor-binding domain (RBD) of …
capsid-like particle (CLP)-based vaccines displaying the receptor-binding domain (RBD) of …
[PDF][PDF] Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity
C Fougeroux - edepot.wur.nl
Results Development and characterization of a CLP-based SARS-COV-2 vaccine. The RBD
(amino acids (aa) 319-591) of the SARS-CoV-2 spike protein (Sequence ID: QIA20044. 1) …
(amino acids (aa) 319-591) of the SARS-CoV-2 spike protein (Sequence ID: QIA20044. 1) …
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity
C Fougeroux, L Goksøyr, M Idorn… - Nature …, 2021 - econpapers.repec.org
The rapid development of a SARS-CoV-2 vaccine is a global priority. Here, we develop two
capsid-like particle (CLP)-based vaccines displaying the receptor-binding domain (RBD) of …
capsid-like particle (CLP)-based vaccines displaying the receptor-binding domain (RBD) of …
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity
C Fougeroux, L Goksøyr, M Idorn, V Soroka… - Nature …, 2021 - ideas.repec.org
The rapid development of a SARS-CoV-2 vaccine is a global priority. Here, we develop two
capsid-like particle (CLP)-based vaccines displaying the receptor-binding domain (RBD) of …
capsid-like particle (CLP)-based vaccines displaying the receptor-binding domain (RBD) of …
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity.
C Fougeroux, L Goksøyr, M Idorn, V Soroka, SK Myeni… - 2021 - cabidigitallibrary.org
The rapid development of a SARS-CoV-2 vaccine is a global priority. Here, we develop two
capsid-like particle (CLP)-based vaccines displaying the receptor-binding domain (RBD) of …
capsid-like particle (CLP)-based vaccines displaying the receptor-binding domain (RBD) of …
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity
C Fougeroux, L Goksøyr, M Idorn… - Nature …, 2021 - research.regionh.dk
The rapid development of a SARS-CoV-2 vaccine is a global priority. Here, we develop two
capsid-like particle (CLP)-based vaccines displaying the receptor-binding domain (RBD) of …
capsid-like particle (CLP)-based vaccines displaying the receptor-binding domain (RBD) of …
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity
C Fougeroux, L Goksoyr, M Idorn… - Nature …, 2021 - ub01.uni-tuebingen.de
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong
virus neutralization activity Capsid-like particles decorated with the SARS-CoV-2 receptor-binding …
virus neutralization activity Capsid-like particles decorated with the SARS-CoV-2 receptor-binding …
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity.
C Fougeroux, L Goksøyr, M Idorn… - Nature …, 2021 - search.ebscohost.com
The rapid development of a SARS-CoV-2 vaccine is a global priority. Here, we develop two
capsid-like particle (CLP)-based vaccines displaying the receptor-binding domain (RBD) of …
capsid-like particle (CLP)-based vaccines displaying the receptor-binding domain (RBD) of …
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity
C Fougeroux, L Goksøyr, M Idorn… - Nature …, 2021 - ui.adsabs.harvard.edu
The rapid development of a SARS-CoV-2 vaccine is a global priority. Here, we develop two
capsid-like particle (CLP)-based vaccines displaying the receptor-binding domain (RBD) of …
capsid-like particle (CLP)-based vaccines displaying the receptor-binding domain (RBD) of …